Alterity Therapeutics (ATHE) EBITDA (2009 - 2024)
Alterity Therapeutics (ATHE) posted quarterly EBITDA of -$12.8 million for Q2 2024, down 36.64% year-over-year from -$20.1 million in Q3 2023, and down 36.64% quarter-over-quarter from -$9.3 million in Q2 2023.
Alterity Therapeutics (ATHE) EBITDA (2009 - 2024) Analysis & Trends
Alterity Therapeutics' EBITDA history runs 9 years deep, the most recent figure standing at -$12.8 million for Q2 2024.
- In Q2 2024, EBITDA fell 36.64% year-over-year to -$12.8 million; the TTM figure through Jun 2024 stood at -$35.3 million (down 12.56% YoY), while the FY2025 annual figure was -$7.8 million, up 39.02% from the prior year.
- EBITDA for Q2 2024 stood at -$12.8 million, down from -$9.3 million in the prior quarter.
- The five-year high for EBITDA was -$9.3 million in Q2 2022, with the low at -$12.8 million in Q2 2024.
- The 3-year median for EBITDA is -$9.3 million (2023), against an average of -$10.5 million.
- The sharpest annual moves came in 2023 and 2024: EBITDA slipped 0.1% in 2023, then slumped 36.64% in 2024.
- Alterity Therapeutics' EBITDA stood at -$9.3 million in 2022, then decreased by 0.1% to -$9.3 million in 2023, then plunged by 36.64% to -$12.8 million in 2024.
- Business Quant data shows ATHE's EBITDA at -$12.8 million in Q2 2024, -$9.3 million in Q2 2023, and -$9.3 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.29 Bn | 132.43 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 86.58 Bn | 78.58 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.08 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 61.87 Bn | 56.73 Bn | 52.00 Mn | -815.00 Mn |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn | 325.05 Mn |
| 6 | Alnylam Pharmaceuticals | 31.51 Bn | 28.20 Bn | 992.69 Mn | 231.44 Mn |
| 7 | BioNTech SE | 28.90 Bn | 10.51 Bn | 668.28 Mn | -375.75 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | -1.55 Mn |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - | 133.12 Mn |
| 10 | Alterity Therapeutics | 50.86 Mn | 18.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -12.76 Mn |
| Jun 30, 2023 | -9.34 Mn |
| Jun 30, 2022 | -9.33 Mn |
| Dec 31, 2019 | -3.85 Mn |
| Jun 30, 2019 | -8.82 Mn |
| Dec 31, 2018 | -3.83 Mn |
| Jun 30, 2018 | -6.38 Mn |
| Dec 31, 2017 | -2.78 Mn |
| Jun 30, 2017 | -5.38 Mn |
| Dec 31, 2016 | -2.74 Mn |
| Jun 30, 2010 | -4.34 Mn |
| Jun 30, 2009 | -5.71 Mn |